Search Results - "Dudek, Aleksandra M"
-
1
ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death
Published in Autophagy (01-09-2013)“…Calreticulin surface exposure (ecto-CALR), ATP secretion, maturation of dendritic cells (DCs) and stimulation of T cells are prerequisites for anticancer…”
Get full text
Journal Article -
2
Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin
Published in Cancer research (Chicago, Ill.) (15-04-2015)“…Systemic chemotherapy generally has been considered immunosuppressive, but it has become evident that certain chemotherapeutic drugs elicit immunogenic danger…”
Get full text
Journal Article -
3
LINC00857 expression predicts and mediates the response to platinum‐based chemotherapy in muscle‐invasive bladder cancer
Published in Cancer medicine (Malden, MA) (01-07-2018)“…Approximately 20% of patients with bladder cancer are diagnosed with muscle‐invasive disease (MIBC). The treatment involves radical cystectomy, but almost 50%…”
Get full text
Journal Article -
4
Autophagy-dependent suppression of cancer immunogenicity and effector mechanisms of innate and adaptive immunity
Published in Oncoimmunology (01-10-2013)“…The inspection of the mechanisms through which autophagy modulates immunogenic cell death revealed that the autophagic response of cancer cells to reactive…”
Get full text
Journal Article -
5
An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAFV600E inhibitor-resistant metastatic melanoma cells
Published in Autophagy (02-09-2017)“…The ingrained capacity of melanoma cells to rapidly evolve toward an aggressive phenotype is manifested by their increased ability to develop drug-resistance,…”
Get full text
Journal Article -
6
Molecular Phenotyping of AR Signaling for Predicting Targeted Therapy in Castration Resistant Prostate Cancer
Published in Frontiers in oncology (19-08-2021)“…Castration-resistant prostate cancer (CRPC) is defined by resistance of the tumor to androgen deprivation therapy (ADT). Several molecular changes,…”
Get full text
Journal Article -
7
Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity
Published in Frontiers in immunology (11-12-2013)“…Dendritic cells (DCs) are the sentinel antigen-presenting cells of the immune system; such that their productive interface with the dying cancer cells is…”
Get full text
Journal Article -
8
Prognostic relevance of urinary bladder cancer susceptibility loci
Published in PloS one (25-02-2014)“…In the last few years, susceptibility loci have been identified for urinary bladder cancer (UBC) through candidate-gene and genome-wide association studies…”
Get full text
Journal Article -
9
Urinary bladder cancer susceptibility markers. What do we know about functional mechanisms?
Published in International Journal of Molecular Sciences (10-06-2013)“…Genome-wide association studies (GWAS) have been successful in the identification of the several urinary bladder cancer (UBC) susceptibility loci, pointing…”
Get full text
Journal Article Book Review -
10
Inducers of immunogenic cancer cell death
Published in Cytokine & growth factor reviews (01-08-2013)“…Abstract Recently, cytokine-based pro-tumourigenic signalling has been found to play a major role in the immune system's pro-tumourigenic activity. On the…”
Get full text
Journal Article -
11
Cancer immunogenicity, danger signals, and DAMPs: What, when, and how?
Published in BioFactors (Oxford) (01-07-2013)“…Cancer immunosurvelliance usually leads to formation of cancer cells that have been “immunoedited” to resist anti‐tumor immunity. One of the consequences of…”
Get full text
Journal Article -
12
Immunogenic cell death
Published in The International journal of developmental biology (01-01-2015)“…Currently, it is widely acknowledged that a proactive anticancer immunosurveillance mechanism takes part in the rejection of neoplastic lesions before they…”
Get full text
Journal Article -
13
Identification of long non-coding RNAs that stimulate cell survival in bladder cancer
Published in Oncotarget (23-05-2017)“…For many years, research on the biology underlying bladder cancer focused on protein-coding genes which cover only about 3% of the human genome. Recently, it…”
Get full text
Journal Article -
14
Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk
Published in Cellular oncology (Dordrecht) (01-10-2018)“…Purpose Genome-wide association studies (GWAS) have led to the identification of a bladder cancer susceptibility variant (rs710521) in a non-coding intergenic…”
Get full text
Journal Article -
15
Melphalan, Antimelanoma Immunity, and Inflammation--Response
Published in Cancer research (Chicago, Ill.) (15-12-2015)Get full text
Journal Article -
16
An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAF V600E inhibitor-resistant metastatic melanoma cells
Published in Autophagy (02-09-2017)“…The ingrained capacity of melanoma cells to rapidly evolve toward an aggressive phenotype is manifested by their increased ability to develop drug-resistance,…”
Get full text
Journal Article -
17
-
18
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
Published in Frontiers in immunology (20-11-2015)“…The immunogenicity of malignant cells has recently been acknowledged as a critical determinant of efficacy in cancer therapy. Thus, besides developing direct…”
Get full text
Journal Article -
19
Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer
Published in Human molecular genetics (15-10-2014)“…Genome-wide association studies (GWAS) of urinary bladder cancer (UBC) have yielded common variants at 12 loci that associate with risk of the disease. We…”
Get full text
Journal Article -
20
LINC 00857 expression predicts and mediates the response to platinum‐based chemotherapy in muscle‐invasive bladder cancer
Published in Cancer medicine (Malden, MA) (01-07-2018)“…Abstract Approximately 20% of patients with bladder cancer are diagnosed with muscle‐invasive disease ( MIBC ). The treatment involves radical cystectomy, but…”
Get full text
Journal Article